Mara Ten Kate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mara Ten Kate has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Pieter Jelle Visser
Neurodegeneration, Amsterdam Neuroscience, Amsterdam, Netherlands
2 shared publications - Abdul Hye
King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK
1 shared publication - Alberto Lleó
Department of Neurology, Institut d’Investigacions Biomèdiques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1 shared publication - Alejo J. Nevado Holgado
Department of Psychiatry, University of Oxford, Oxford, UK
1 shared publication - Alison L. Baird
Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK
1 shared publication Alle Meije Wink
Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Functional Connectivity and Longitudinal Changes in Amyloid Pathology in Cognitively Healthy Older Adults
Background: Accumulation of amyloid beta in the brain is one of the first events in Alzheimer’s disease (AD) and starts decades before symptoms arise. It has been hypothesized that brain areas with higher levels of neuronal activation (‘hubs’) are more prone to amyloid deposition. In this study, we examined the regional relationship between cortical hubs and longitudinal changes in amyloid pathology in a sample of cognitively healthy older subjects.Method: Participants were included from the EMIF‐AD PreclinAD cohort, a longitudinal study in cognitively healthy older monozygotic twins. Standard resting state functional MRI pre‐processing was performed with fMRIprep. Individual connectivity matrices were generated as the pairwise timeseries correlation between 100 regions in the Schaeffer atlas, and binarized using a proportional threshold of 0.25. Regional degree, the number of connections of each region, was taken as a continuous measure of functional 'hubness'. Degree was computed within the 100 individual regions, and averaged within 7 resting state networks. Dynamic [18F]Flutemetamol PET scans were used to visually assess amyloid status, and to quantify global and regional binding potential (BPND) at baseline and follow‐up (mean 4.4±0.5 years). We first assessed whether baseline regional degree could predict change in amyloid status using GEE to account for familial clustering. Next, we performed ROI‐wise analyses, assessing the relationship between group‐average regional values of degree and quantitative BPND (baseline and change) in the whole sample and according to amyloid subgroups (negative stable, converter, positive stable).Result: We included 124 subjects (age 68.3±6.4, female 54%). In baseline amyloid visually negative subjects (n=111), a lower mean degree in the default mode network (β=‐0.26, p=0.008) was associated with higher chance of conversion from negative to positive amyloid status. In the ROI‐wise analyses, a lower degree was associated with higher baseline BPND and larger rate of increase over time (Figure 1). This relationship was most pronounced in the converter group (Figure 2).Conclusion: We found that in cognitively healthy individuals, decrease rather than increase in functional hubness is associated with amyloid load and accumulation. Possibly in this population of older adults, functional hubs are already affected by ageing, or early pathology.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Open AccessFunctional Connectivity and Longitudinal Changes in Amyloid Pathology in Cognitively Healthy Older Adults
Background: Accumulation of amyloid beta in the brain is one of the first events in Alzheimer’s disease (AD) and starts decades before symptoms arise. It has been hypothesized that brain areas with higher levels of neuronal activation (‘hubs’) are more prone to amyloid deposition. In this study, we examined the regional relationship between cortical hubs and longitudinal changes in amyloid pathology in a sample of cognitively healthy older subjects.Method: Participants were included from the EMIF‐AD PreclinAD cohort, a longitudinal study in cognitively healthy older monozygotic twins. Standard resting state functional MRI pre‐processing was performed with fMRIprep. Individual connectivity matrices were generated as the pairwise timeseries correlation between 100 regions in the Schaeffer atlas, and binarized using a proportional threshold of 0.25. Regional degree, the number of connections of each region, was taken as a continuous measure of functional 'hubness'. Degree was computed within the 100 individual regions, and averaged within 7 resting state networks. Dynamic [18F]Flutemetamol PET scans were used to visually assess amyloid status, and to quantify global and regional binding potential (BPND) at baseline and follow‐up (mean 4.4±0.5 years). We first assessed whether baseline regional degree could predict change in amyloid status using GEE to account for familial clustering. Next, we performed ROI‐wise analyses, assessing the relationship between group‐average regional values of degree and quantitative BPND (baseline and change) in the whole sample and according to amyloid subgroups (negative stable, converter, positive stable).Result: We included 124 subjects (age 68.3±6.4, female 54%). In baseline amyloid visually negative subjects (n=111), a lower mean degree in the default mode network (β=‐0.26, p=0.008) was associated with higher chance of conversion from negative to positive amyloid status. In the ROI‐wise analyses, a lower degree was associated with higher baseline BPND and larger rate of increase over time (Figure 1). This relationship was most pronounced in the converter group (Figure 2).Conclusion: We found that in cognitively healthy individuals, decrease rather than increase in functional hubness is associated with amyloid load and accumulation. Possibly in this population of older adults, functional hubs are already affected by ageing, or early pathology.
- Open Access
- 3 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1610
Sex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Background: physiological differences between males and females could contribute to the development of Alzheimer’s Disease (AD). Here, we examined metabolic pathways that may lead to precision medicine initiatives. Methods: We explored whether sex modifies the association of 540 plasma metabolites with AD endophenotypes including diagnosis, cerebrospinal fluid (CSF) biomarkers, brain imaging, and cognition using regression analyses for 695 participants (377 females), followed by sex-specific pathway overrepresentation analyses, APOE ε4 stratification and assessment of metabolites’ discriminatory performance in AD. Results: In females with AD, vanillylmandelate (tyrosine pathway) was increased and tryptophan betaine (tryptophan pathway) was decreased. The inclusion of these two metabolites (area under curve (AUC) = 0.83, standard error (SE) = 0.029) to a baseline model (covariates + CSF biomarkers, AUC = 0.92, SE = 0.019) resulted in a significantly higher AUC of 0.96 (SE = 0.012). Kynurenate was decreased in males with AD (AUC = 0.679, SE = 0.046). Conclusions: metabolic sex-specific differences were reported, covering neurotransmission and inflammation pathways with AD endophenotypes. Two metabolites, in pathways related to dopamine and serotonin, were associated to females, paving the way to personalised treatment.
- 3 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1610
Open AccessSex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Background: physiological differences between males and females could contribute to the development of Alzheimer’s Disease (AD). Here, we examined metabolic pathways that may lead to precision medicine initiatives. Methods: We explored whether sex modifies the association of 540 plasma metabolites with AD endophenotypes including diagnosis, cerebrospinal fluid (CSF) biomarkers, brain imaging, and cognition using regression analyses for 695 participants (377 females), followed by sex-specific pathway overrepresentation analyses, APOE ε4 stratification and assessment of metabolites’ discriminatory performance in AD. Results: In females with AD, vanillylmandelate (tyrosine pathway) was increased and tryptophan betaine (tryptophan pathway) was decreased. The inclusion of these two metabolites (area under curve (AUC) = 0.83, standard error (SE) = 0.029) to a baseline model (covariates + CSF biomarkers, AUC = 0.92, SE = 0.019) resulted in a significantly higher AUC of 0.96 (SE = 0.012). Kynurenate was decreased in males with AD (AUC = 0.679, SE = 0.046). Conclusions: metabolic sex-specific differences were reported, covering neurotransmission and inflammation pathways with AD endophenotypes. Two metabolites, in pathways related to dopamine and serotonin, were associated to females, paving the way to personalised treatment.
- Open Access
- 28 April 2020
- Published by Springer Nature in BMC Geriatrics
- Vol. 20 (1) , 1-9
Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study
Ocular imaging receives much attention as a source of potential biomarkers for dementia. In the present study, we analyze these ocular biomarkers in cognitively impaired and healthy participants in a population aged over 90 years (= nonagenarian), and elucidate the effects of age on these biomarkers. For this prospective cross-sectional study, we included individuals from the EMIF-AD 90+ study, consisting of a cognitively healthy (N = 67) and cognitively impaired group (N = 33), and the EMIF-AD PreclinAD study, consisting of cognitively healthy controls aged ≥60 (N = 198). Participants underwent Optical Coherence Tomography (OCT) and fundus photography of both eyes. OCT was used to asses total and individual inner retinal layer thickness in the macular region (Early Treatment Diabetic Retinopathy Study circles) as well as peripapillary retinal nerve fiber layer thickness, fundus images were analyzed with Singapore I Vessel Assessment to obtain 7 retinal vascular parameters. Values for both eyes were averaged. Differences in ocular biomarkers between the 2 nonagenarian groups were analyzed using linear regression, differences between the individual nonagenarian groups and controls were analyzed using generalized estimating equations. Ocular biomarkers did not differ between the healthy and cognitively impaired nonagenarian groups. 19 out of 22 ocular biomarkers assessed in this study differed between either nonagenarian group and the younger controls. The ocular biomarkers assessed in this study were not associated with cognitive impairment in nonagenarians, making their use as a screening tool for dementing disorders in this group limited. However, ocular biomarkers were significantly associated with chronological age, which were very similar to those ascribed to occur in Alzheimer’s Disease.
- 28 April 2020
- Published by Springer Nature in BMC Geriatrics
- Vol. 20 (1) , 1-9
Open AccessOcular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study
Ocular imaging receives much attention as a source of potential biomarkers for dementia. In the present study, we analyze these ocular biomarkers in cognitively impaired and healthy participants in a population aged over 90 years (= nonagenarian), and elucidate the effects of age on these biomarkers. For this prospective cross-sectional study, we included individuals from the EMIF-AD 90+ study, consisting of a cognitively healthy (N = 67) and cognitively impaired group (N = 33), and the EMIF-AD PreclinAD study, consisting of cognitively healthy controls aged ≥60 (N = 198). Participants underwent Optical Coherence Tomography (OCT) and fundus photography of both eyes. OCT was used to asses total and individual inner retinal layer thickness in the macular region (Early Treatment Diabetic Retinopathy Study circles) as well as peripapillary retinal nerve fiber layer thickness, fundus images were analyzed with Singapore I Vessel Assessment to obtain 7 retinal vascular parameters. Values for both eyes were averaged. Differences in ocular biomarkers between the 2 nonagenarian groups were analyzed using linear regression, differences between the individual nonagenarian groups and controls were analyzed using generalized estimating equations. Ocular biomarkers did not differ between the healthy and cognitively impaired nonagenarian groups. 19 out of 22 ocular biomarkers assessed in this study differed between either nonagenarian group and the younger controls. The ocular biomarkers assessed in this study were not associated with cognitive impairment in nonagenarians, making their use as a screening tool for dementing disorders in this group limited. However, ocular biomarkers were significantly associated with chronological age, which were very similar to those ascribed to occur in Alzheimer’s Disease.